We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Chronic Lymphocytic Inflammation With Pontine Perivascular Enhancement Responsive to Steroids and Fatal B-Cell Lymphoma—Reply

Hjalmar J. De Graaff, BSc1; Mike P. Wattjes, MD, PhD2; Annemieke J. Rozemuller, MD, PhD3; Axel Petzold, MD, PhD1; Joep Killestein, MD, PhD1
[+] Author Affiliations
1MS Center Amsterdam, Department of Neurology, VU University Medical Center, Amsterdam, the Netherlands
2MS Center Amsterdam, Department of Radiology, VU University Medical Center, Amsterdam, the Netherlands
3Department of Pathology, VU University Medical Center, Amsterdam, the Netherlands.
JAMA Neurol. 2013;70(11):1459-1460. doi:10.1001/jamaneurol.2013.4757.
Text Size: A A A
Published online


In Reply With interest we read the letter to the editor by Zhang and Wu. As described, our patient presented with recurrent episodes of neurologic deficit, improving after administration of steroids compatible with chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids.1 Eventually, the patient was diagnosed as having lymphomatoid granulomatosis resulting in a B-cell lymphoma. This central nervous system B-cell lymphoma was suggested by magnetic resonance imaging characteristics and biopsy prior to the patient’s death and was confirmed by postmortem autopsy. Microscopic tissue analysis showed a large pontine area (markedly enhancing on brain magnetic resonance imaging) with necrosis and a focal thalamus lesion with large atypical lymphocytes and perivascular infiltrates, including atypical lymphocytes, small lymphocytes, and macrophages, compatible with a B-cell lymphoma. Immunohistochemistry findings indicated large quantities of atypical CD-20–positive cells with some T cells. About 10% to 20% of tumor cells were Epstein-Barr virus–encoded RNA positive. Thus, the final diagnosis of B-cell lymphoma could be confirmed post mortem. We agree that magnetic resonance spectroscopy might be helpful in differentiating inflammatory and neoplastic lesions. However, in the context of chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids, there is limited experience using this method, which does not allow drawing strong conclusions for diagnostic purposes.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





November 1, 2013
Hongliang Zhang, MD, PhD; Jiang Wu, MD, PhD
1Department of Neurology, First Hospital of Jilin University, Changchun, China
JAMA Neurol. 2013;70(11):1459. doi:10.1001/jamaneurol.2013.4074.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...